Kathryn J Swoboda Selected Research

Proteins (Proteins, Gene)

1/2021	Cancer-induced muscle atrophy is determined by intrinsic muscle oxidative capacity.
1/2020	Whole blood survival motor neuron protein levels correlate with severity of denervation in spinal muscular atrophy.
1/2020	Exercise training reverses cancer-induced oxidative stress and decrease in muscle COPS2/TRIP15/ALIEN.
11/2019	Age-dependent SMN expression in disease-relevant tissue and implications for SMA treatment.
1/2018	Novel PLP1 Mutations Identified With Next-Generation Sequencing Expand the Spectrum of PLP1-Associated Leukodystrophy Clinical Phenotypes.
8/2017	Fever-Induced Paroxysmal Weakness and Encephalopathy, a New Phenotype of ATP1A3 Mutation.
1/2016	SMN Protein Can Be Reliably Measured in Whole Blood with an Electrochemiluminescence (ECL) Immunoassay: Implications for Clinical Trials.
7/2015	Astrocytes influence the severity of spinal muscular atrophy.
6/2015	Spinal Muscular Atrophy Biomarker Measurements from Blood Samples in a Clinical Trial of Valproic Acid in Ambulatory Adults.
4/2015	Clinical phenotypes as predictors of the outcome of skipping around DMD exon 45.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kathryn J Swoboda Research Topics

Disease

45	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 01/2023 - 05/2005
4	Spinal Muscular Atrophies of Childhood (Werdnig Hoffman Disease) 01/2022 - 03/2014
3	Alternating hemiplegia of childhood 01/2020 - 01/2015
2	Neoplasms (Cancer) 01/2021 - 01/2020
2	Muscular Atrophy (Muscle Atrophy) 01/2021 - 11/2019
2	Neuromuscular Diseases (Neuromuscular Disease) 01/2021 - 01/2013
2	Motor Neuron Disease (Primary Lateral Sclerosis) 12/2020 - 08/2012
2	Disease Progression 01/2020 - 12/2017
2	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 04/2015 - 03/2011
2	Muscular Diseases (Myopathy) 11/2013 - 02/2009
2	Weight Gain 08/2010 - 01/2009
2	Seizures (Absence Seizure) 06/2008 - 03/2002
1	Atrophy 12/2020
1	Muscle Weakness 12/2020
1	Abnormal Reflex (Hyperreflexia) 12/2020
1	Cachexia 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Polycystic Kidney Diseases (Polycystic Kidney Disease) 10/2019
1	Fibrosis (Cirrhosis) 10/2019
1	Nephrocalcinosis 10/2019
1	Prion Diseases (Transmissible Spongiform Encephalopathies) 01/2019
1	Neurodevelopmental Disorders 11/2018
1	Dystonia (Limb Dystonia) 01/2018
1	Rare Diseases (Rare Disease) 01/2018
1	Pelizaeus-Merzbacher Disease 01/2018
1	Spastic Paraparesis 01/2018
1	Hereditary Spastic Paraplegia 01/2018
1	Premature Obstetric Labor (Premature Labor) 11/2017
1	Ataxia (Dyssynergia) 08/2017
1	Cerebellar Ataxia (Dysmetria) 08/2017
1	Brain Diseases (Brain Disorder) 08/2017
1	Glycogen Storage Disease Type II (Pompe's Disease) 07/2017
1	Arthrogryposis 09/2016
1	Insulin Resistance 12/2015
1	Hypoglycemia (Reactive Hypoglycemia) 12/2015
1	Agenesis of Cerebellar Vermis 05/2015
1	Bethlem myopathy 11/2013
1	Scleroatonic muscular dystrophy 11/2013
1	Muscular Dystrophies (Muscular Dystrophy) 04/2013
1	Epilepsy (Aura) 11/2012
1	Dystonia 12 09/2012
1	Acidosis 08/2012
1	Hyperlipidemias (Hyperlipidemia) 08/2012
1	Hyperglycemia 08/2012
1	Cough 05/2012

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2007
8	nusinersenIBA 01/2023 - 01/2016
8	Biomarkers (Surrogate Marker)IBA 01/2021 - 03/2011
7	Valproic Acid (Depakote)FDA LinkGeneric 01/2018 - 01/2009
5	Adenosine Triphosphatases (ATPase)IBA 01/2020 - 09/2012
4	Carnitine (L-Carnitine)FDA LinkGeneric 01/2018 - 01/2009
3	ZolgensmaIBA 01/2022 - 06/2021
3	Glucose (Dextrose)FDA LinkGeneric 10/2019 - 08/2012
2	RNA Precursors (Precursor, mRNA)IBA 01/2021 - 04/2015
2	CreatinineIBA 01/2020 - 10/2019
2	Blood Proteins (Serum Proteins)IBA 01/2020 - 01/2013
2	CalciumIBA 10/2019 - 03/2014
2	Antisense OligonucleotidesIBA 03/2016 - 01/2016
2	DystrophinIBA 04/2015 - 03/2011
2	Carrier Proteins (Binding Protein)IBA 04/2013 - 03/2011
1	RisdiplamIBA 01/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	Adenosine Triphosphate (ATP)IBA 01/2021
1	ProteomeIBA 01/2021
1	Cysteine (L-Cysteine)FDA Link 01/2021
1	COP9 Signalosome ComplexIBA 01/2020
1	Actins (F Actin)IBA 01/2020
1	Conditioned Culture MediaIBA 01/2020
1	CalbindinsIBA 10/2019
1	Cystatin CIBA 10/2019
1	Calcium-Sensing ReceptorsIBA 10/2019
1	SodiumIBA 10/2019
1	Insulin-Like Growth Factor Binding ProteinsIBA 10/2019
1	Prion ProteinsIBA 01/2019
1	PterinsIBA 01/2018
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2018
1	human GAA protein (Myozyme)FDA Link 07/2017
1	NeurocalcinIBA 01/2017
1	Ion Channels (Ion Channel)IBA 09/2016
1	Messenger RNA (mRNA)IBA 03/2016
1	Blood Glucose (Blood Sugar)IBA 12/2015
1	Insulin (Novolin)FDA Link 12/2015
1	Small Interfering RNA (siRNA)IBA 05/2015
1	Vitamin D FDA LinkGeneric 03/2014
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 11/2013
1	CollagenIBA 11/2013
1	Transforming Growth Factors (Transforming Growth Factor)IBA 04/2013
1	Fatty Acids (Saturated Fatty Acids)IBA 08/2012
1	Oxygen (Dioxygen)IBA 05/2012
1	Connexin 43 (Connexin43)IBA 04/2011
1	disodium salt olean-11,13(18)-diene-3,30-diol dihemiphthalateIBA 04/2011

Therapy/Procedure

18	Therapeutics 01/2022 - 11/2002
4	Denervation 12/2020 - 05/2005
1	Mechanical Ventilators (Ventilator) 01/2022
1	Drug Therapy (Chemotherapy) 01/2020
1	Cesarean Section (Caesarean Section) 11/2017
1	Enzyme Replacement Therapy 07/2017
1	Spinal Injections 01/2016
1	Resistance Training 10/2015
1	Noninvasive Ventilation 05/2012